Cargando…

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR

Owing to its pharmacodynamics and posology, the use of regadenoson for stress cardiac magnetic resonance (CMR) has potential advantages over other vasodilators. We sought to evaluate the safety, hemodynamic response and diagnostic performance of regadenoson stress-CMR in routine clinical practice. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñiz-Sáenz-Diez, Javier, Ezponda, Ana, Caballeros, Meylin, de la Fuente, Ana, Gavira, Juan J., Bastarrika, Gorka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520095/ https://www.ncbi.nlm.nih.gov/pubmed/37354385 http://dx.doi.org/10.1007/s10554-023-02877-z

Ejemplares similares

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Cardiac magnetic resonance characterization of COVID-19 myocarditis
por: Caballeros Lam, Meylin, et al.
Publicado: (2020)

Caracterización de la miocarditis por COVID-19 mediante resonancia magnética cardiaca
por: Caballeros Lam, Meylin, et al.
Publicado: (2020)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children
por: Schloss, Brian, et al.
Publicado: (2021)

Feasibility and prognostic value of stress-perfusion CMR in obesity
por: Shah, Ravi, et al.
Publicado: (2012)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina
por: Beslic, Nermina, et al.
Publicado: (2016)

Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging
por: Thomas, Dustin M., et al.
Publicado: (2017)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Acute Eosinophilic Pneumonia Following mRNA COVID-19 Vaccination: A Case Report
por: Barrio Piqueras, Miguel, et al.
Publicado: (2022)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Feasibility of quantitative perfusion CMR in patients with poor left ventricular function
por: Sammut, Eva, et al.
Publicado: (2013)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Feasibility of detecting myocardial ischemia using first-pass contrast MRI and regadenoson
por: Lyons, Matthew, et al.
Publicado: (2012)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Feasibility and results of acute cardiac stress MRI with regadenoson for risk stratification of COPD-patients with NSTEMI
por: Range, Felix T, et al.
Publicado: (2015)

Pulmonary arterial enlargement predicts long-term survival in COPD patients
por: de-Torres, Juan P., et al.
Publicado: (2018)

The yield of stress perfusion CMR in asymptomatic diabetics
por: O h-Ici, Darach, et al.
Publicado: (2011)

Initial results of a new very rapid rest/regadenoson stress myocardial perfusion protocol in patients with atrial fibrillation
por: Chang, Lowell, et al.
Publicado: (2014)

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study
por: Tejani, Furqan H., et al.
Publicado: (2014)

Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
por: Reyes, Eliana, et al.
Publicado: (2019)

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison
por: Gibarti, Claudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nnuaf8gteffj4knb5fmn9s573b